How many patents does
Medigene have?
patents
455
families
52
granted
138
applications
317
US
119
EP
73
JP
19
CN
15
WO
12
KR
2
RoW
215
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Medigene
Top ten assignees appearing on patents
2009 - 2018
| medigene | 299 |
| immunocore | 56 |
| syncore biotechnology company | 26 |
| adaptimmune | 21 |
| avidex | 19 |
| catherex | 11 |
| heinrich haas | 2 |
| medigene oncology | 2 |
| biomedical international r + d | 2 |
| medidzhen | 1 |
2009
| medigene | 70 |
| immunocore | 15 |
| avidex | 3 |
| heinrich haas | 1 |
| medidzhen | 1 |
| ehvideks | 1 |
2018
| medigene | 16 |
| syncore biotechnology company | 2 |
| adaptimmune | 1 |
| avidex | 1 |
| fougera pharmaceuticals | 1 |
Medigene
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| method of producing a cationic liposomal preparation comprising a lipophilic compound | 42 | 2002 |
| treatment of tumors using specific anti-l1 antibody | 36 | 2007 |
| t cell receptor display | 28 | 2002 |
| improved liposomal formulations of lipophilic compounds | 24 | 2010 |
| medicament for the treatment of viral skin and tumour diseases | 22 | 2001 |
| high affinity ny-eso t cell receptor | 21 | 2004 |
| treatment of triple receptor negative breast cancer | 20 | 2006 |
| salt of cd 80 antagonist | 19 | 2006 |
| immunomodulating heterocyclic compounds | 17 | 2003 |
| use of cationic liposomes comprising paclitaxel | 14 | 2003 |